Beyond IVF: Redefining the Future of Fertility and Reproductive Healthcare

In an exclusive interview with Dr. Hrishikesh Pai, a leading global authority on IVF, fertility and reproductive healthcare, explores the remarkable evolution of reproductive medicine, the growing role of advanced technologies in fertility treatment, and the changing landscape of women’s healthcare in India.
Drawing on over four decades of clinical experience, Dr. Pai shares insights on breaking the stigma surrounding infertility, making fertility care more accessible, and the importance of combining medical innovation with compassionate, patient-centric treatment.
He also reflects on his contributions to medical research, education and global healthcare initiatives, while sharing his vision for the next generation of fertility specialists.
1. What inspired you to specialise in reproductive medicine, and was there a defining experience in your professional journey that strengthened your commitment to helping couples achieve parenthood?
My journey into reproductive medicine was driven by a deep interest in women’s health and the desire to make a meaningful difference in people’s lives. Early in my career as an obstetrician and gynaecologist, I realised that infertility was an area where medical intervention could have an incredibly profound emotional and social impact. For couples struggling to conceive, parenthood is often a deeply cherished dream, and the inability to achieve it can affect their emotional well-being, relationships and confidence.
What particularly drew me towards this speciality was the opportunity to combine clinical expertise, scientific research and emerging technology to address a challenge that affects millions of couples. As I began working more closely in infertility treatment and assisted reproductive technologies, I saw how advancements in IVF could transform outcomes and offer hope to couples who had very limited options earlier.
Over the years, one of the most rewarding aspects of my profession has been witnessing couples who have endured years of uncertainty finally experience parenthood. These experiences have reinforced my belief that reproductive medicine is not merely about medical procedures; it is about understanding individual circumstances, providing reassurance and helping people navigate one of the most important journeys of their lives. That sense of responsibility continues to motivate me even after more than 40 years in this field.
2. With more than 40 years of clinical experience, what are some of the most important lessons you have learnt about infertility, patient care and the changing understanding of reproductive health?
One of the biggest lessons I have learnt is that infertility is never just a medical condition. It is an experience that affects individuals and couples emotionally, psychologically and socially. Therefore, treating infertility requires much more than identifying a clinical problem and recommending a treatment. It requires listening to patients, understanding their expectations and designing an approach that is appropriate for their individual needs.
The field of reproductive medicine has evolved tremendously over the last four decades. When I started my career, the options available to couples were considerably limited. Today, advancements in IVF, ICSI, IMSI, embryo freezing, genetic testing, fertility preservation and laboratory technologies have significantly expanded the possibilities of treatment. We are also seeing the growing role of artificial intelligence in embryo assessment and selection, which can support more informed clinical decision-making.
However, one important lesson remains unchanged: technology can enhance medical expertise, but it cannot replace the judgement and compassion of a doctor. Every patient has a different medical history, age, ovarian reserve, reproductive health profile and set of expectations. There is no universal treatment protocol that works for everyone.
I also believe that infertility should be addressed earlier and more openly. Awareness about reproductive health, age-related fertility decline, lifestyle factors, male infertility and fertility preservation needs to improve. We must move away from the tendency to place the entire responsibility of infertility on women. Both partners need to be evaluated, supported and involved in the treatment journey.
Ultimately, my philosophy has been to combine scientific advancement with ethical, transparent and personalised patient care.
3. You have been associated with several national and international organisations, including FIGO. How has this global exposure influenced your approach to women’s healthcare and fertility treatment in India?
My association with national and international organisations has given me a much broader perspective on the challenges and opportunities in reproductive healthcare. Through my involvement with organisations such as FOGSI, FIGO, the International Federation of Fertility Societies and the American Society for Reproductive Medicine, I have had the opportunity to engage with experts, researchers and healthcare leaders from across the world.
One of the most important learnings from this exposure is that while reproductive health challenges may differ across geographies, the fundamental need for accessible, safe, ethical and high-quality healthcare remains universal. International collaborations allow us to understand emerging research, exchange clinical experiences and bring evidence-based practices into our healthcare ecosystem.
India has made remarkable progress in reproductive medicine, particularly in IVF and assisted reproductive technologies. However, we still have significant ground to cover in terms of awareness, affordability, infrastructure and access to quality treatment, particularly beyond major metropolitan cities.
My association with FIGO has also reinforced the importance of looking at women’s healthcare beyond individual clinical interventions. Issues such as maternal health, anaemia, cervical cancer prevention, reproductive rights and quality of maternity care require a coordinated approach involving doctors, institutions, policymakers and communities.
I strongly believe that India should not simply adopt international advancements but also contribute to shaping global conversations in reproductive medicine. We have the clinical talent, scientific capability and patient volumes to become a significant contributor to innovation and research in this field.
4. Beyond clinical practice, you have contributed to medical education, research and healthcare policy. Which of these contributions do you consider particularly meaningful, and why?
I consider all three areas deeply interconnected because improving healthcare requires us to treat patients, educate future professionals and strengthen the systems within which healthcare is delivered.
However, some of my most meaningful contributions have been those that have created an impact beyond my individual clinical practice. One such initiative is the FOGSI Manyata programme, which focuses on improving the quality of maternity care through standardised protocols, training, assessment and certification of healthcare facilities. As Chief Administrator of this initiative, I have had the opportunity to contribute towards strengthening maternity care infrastructure and clinical practices across India.
Another important initiative has been the Pradhan Mantri Surakshit Matritva Abhiyan (PMSMA), which promotes access to antenatal check-ups for pregnant women. I have also been associated with initiatives such as the Anaemia Mukt Bharat campaign, cervical cancer prevention and women’s health awareness programmes. These efforts are particularly meaningful because they take healthcare beyond hospital settings and bring preventive and quality care closer to communities.
On the academic front, I have always believed that knowledge becomes more valuable when it is shared. Over the years, I have delivered more than 800 lectures, contributed to over 65 book chapters, edited 18 books, published more than 42 research papers and contributed to the development of clinical practice guidelines. As a professor of reproductive medicine, I also consider teaching and mentoring young doctors an important responsibility.
If I were to identify one common thread across these contributions, it would be the belief that healthcare improvement must be sustainable. We need skilled doctors, informed patients, strong institutions and policies that translate medical knowledge into better outcomes. That is the kind of impact I have always aspired to create.
5. What is your vision for the next generation of fertility specialists in India, and what changes would you like to see in how infertility and reproductive health are understood and addressed?
My vision for the next generation of fertility specialists is that they should be scientifically advanced, technologically equipped and, above all, deeply compassionate. Reproductive medicine is evolving rapidly, with developments in artificial intelligence, genetics, embryology, fertility preservation and precision medicine. Young specialists must remain updated with these advancements and develop the ability to apply them responsibly in clinical practice.
I would particularly like to see greater emphasis on evidence-based treatment, research, ethical practices and multidisciplinary collaboration. Fertility specialists should understand that successful treatment is not simply about adopting the latest technology; it is about identifying the right intervention for the right patient at the right time. Artificial intelligence, for instance, can support embryo assessment and clinical decision-making, but the experience and judgement of the treating specialist will remain central to patient care.
Another important change I would like to see is a shift in how society perceives infertility. It should no longer be surrounded by stigma, misconceptions or unnecessary social pressure. Infertility is a medical condition that can affect both men and women, and conversations around it need to become more open, informed and inclusive. We also need to encourage people to understand reproductive health earlier in life, including the impact of age, lifestyle, medical conditions and delayed family planning.
Accessibility is equally important. Advanced fertility treatment should not remain restricted to a small section of society or a handful of large cities. We need to strengthen training, infrastructure and affordable treatment models so that quality reproductive healthcare reaches more people across India.
Ultimately, I would like the next generation of specialists to build on the progress we have made while keeping the patient at the centre of every decision. Our responsibility is not just to advance the science of reproduction but also to make the journey towards parenthood more informed, ethical, accessible and humane.



